{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreid6oas5blqvwunkefet6tgerasznh2hbnu3dccdcweytjg36a4zde",
    "uri": "at://did:plc:itdwwrxvp5plq2i6rsanlqio/app.bsky.feed.post/3mlueeuy2nqh2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibdhyzbmjd35gf6zt5hnrwl3tocaxac6fkbdhcjs4auyrd53bxp7i"
    },
    "mimeType": "image/jpeg",
    "size": 205823
  },
  "path": "/politics/488711/supreme-court-mifepristone-danco-laboratories-louisiana-stay",
  "publishedAt": "2026-05-14T22:30:00.000Z",
  "site": "https://www.vox.com",
  "tags": [
    "Abortion",
    "Health Care",
    "Policy",
    "Politics",
    "Supreme Court"
  ],
  "textContent": "A common abortion drug survived a second brush with the Supreme Court, leaving it accessible while justices decide its fate in a future ruling. The Court issued a brief order Thursday evening, which indefinitely blocks a lower court order targeting the drug mifepristone. The Court’s order in Danco Laboratories v. Louisiana is not permanent, but […]",
  "title": "Mifepristone survives another Supreme Court scare — for now",
  "updatedAt": "2026-05-14T22:24:59.000Z"
}